<amendment session="110" chamber="s" number="1039" updated="2022-02-03T05:23:53Z">
  <amends type="s" number="1082" sequence=""/>
  <status datetime="2007-05-09">fail</status>
  <sponsor bioguide_id="G000386"/>
  <offered datetime="2007-05-03"/>
  <description>To clarify the authority of the Office of Surveillance and Epidemiology with respect to postmarket drug safety pursuant to recommendations by the Institute of Medicine.</description>
  <actions>
    <vote datetime="2007-05-09" how="roll" result="fail" roll="154">
      <text>Amendment SA 1039 not agreed to in Senate by Yea-Nay Vote. 46 - 47. Record Vote Number: 154.</text>
    </vote>
    <action datetime="2007-05-09">
      <text>Considered by Senate.</text>
      <reference ref="CR S5759, S5768-5769, S5771-5772" label="consideration"/>
    </action>
    <action datetime="2007-05-08">
      <text>Amendment SA 1039 proposed by Senator Brown for Senator Grassley. (consideration: CR S5705-5706; text: CR S5705) To clarify the authority of the Office of Surveillance and Epidemiology with respect to postmarket drug safety pursuant to recommendations by the Institute of Medicine.</text>
    </action>
    <action datetime="2007-05-09">
      <text>Senate amendment not agreed to: Amendment SA 1039 not agreed to in Senate by Yea-Nay Vote. 46 - 47. Record Vote Number: 154.</text>
    </action>
    <action datetime="2007-05-09">
      <text>Roll call votes on amendments in Senate: Amendment SA 1039 not agreed to in Senate by Yea-Nay Vote. 46 - 47. Record Vote Number: 154.</text>
    </action>
    <action datetime="2007-05-08">
      <text>Senate amendment proposed (on the floor): Amendment SA 1039 proposed by Senator Brown for Senator Grassley.</text>
      <reference ref="CR S5705-5706" label="consideration"/>
      <reference ref="CR S5705" label="text"/>
    </action>
    <action datetime="2007-05-03">
      <text>Senate amendment submitted</text>
    </action>
  </actions>
</amendment>
